Improta G - Search Results

1

New developments in the management of advanced melanoma - role of pembrolizumab.

Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F. Improta G, et al. Onco Targets Ther. 2015 Sep 14;8:2535-43. doi: 10.2147/OTT.S72823. eCollection 2015. Onco Targets Ther. 2015. PMID: 26396529 Free PMC article. Review.

2

Biological insights into BRAF^V600 mutations in melanoma patient: Not mere therapeutic targets.

Improta G, Pelosi G, Tamborini E, Donia M, Santinami M, de Braud F, Fraggetta F. Improta G, et al. Oncoimmunology. 2013 Aug 1;2(8):e25594. doi: 10.4161/onci.25594. Epub 2013 Jul 3. Oncoimmunology. 2013. PMID: 24179707 Free PMC article.

3

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance.

Improta G, Pettinato A, Gieri S, Scandurra G, Skovrider-Ruminski W, Høgdall E, Fraggetta F. Improta G, et al. Oncol Lett. 2016 Jan;11(1):393-398. doi: 10.3892/ol.2015.3863. Epub 2015 Nov 5. Oncol Lett. 2016. PMID: 26870223 Free PMC article.

4

Oral malignant melanoma: A report of two cases with BRAF molecular analysis.

Soma PF, Pettinato A, Agnone AM, Donia C, Improta G, Fraggetta F. Soma PF, et al. Among authors: improta g. Oncol Lett. 2014 Sep;8(3):1283-1286. doi: 10.3892/ol.2014.2314. Epub 2014 Jul 4. Oncol Lett. 2014. PMID: 25120707 Free PMC article.

5

PIK3CA in ovarian clear cell carcinoma.

Zannoni GF, Improta G, Fraggetta F. Zannoni GF, et al. Among authors: improta g. Hum Pathol. 2014 Dec;45(12):2514. doi: 10.1016/j.humpath.2014.07.023. Epub 2014 Aug 23. Hum Pathol. 2014. PMID: 25245602 No abstract available.

6

Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.

Improta G, Zupa A, Possidente L, Tartarone A, Pedicini P, Nappi A, Molinari S, Fraggetta F, Vita G. Improta G, et al. Oncol Lett. 2013 May;5(5):1741-1743. doi: 10.3892/ol.2013.1255. Epub 2013 Mar 14. Oncol Lett. 2013. PMID: 23761841 Free PMC article.

7

Prostate needle biopsy: what we do and what should be improved.

Fraggetta F, Pepe P, Improta G, Aragona F, Colecchia M. Fraggetta F, et al. Among authors: improta g. Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):130-8. Anal Quant Cytopathol Histpathol. 2013. PMID: 24344499 Review.

8

Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.

Improta G, Pettinato A, Høgdall E, Santeusanio G, Vatrano S, Fraggetta F, Zannoni GF. Improta G, et al. Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):631-636. doi: 10.1097/PAI.0000000000000662. Appl Immunohistochem Mol Morphol. 2019. PMID: 29629954 Review.

9

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.

Zannoni GF, Improta G, Pettinato A, Brunelli C, Troncone G, Scambia G, Fraggetta F. Zannoni GF, et al. Among authors: improta g. J Clin Pathol. 2016 Dec;69(12):1088-1092. doi: 10.1136/jclinpath-2016-203776. Epub 2016 May 6. J Clin Pathol. 2016. PMID: 27153872

10

FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.

Zannoni GF, Improta G, Petrillo M, Pettinato A, Scambia G, Fraggetta F. Zannoni GF, et al. Among authors: improta g. Oncol Lett. 2016 Aug;12(2):1159-1163. doi: 10.3892/ol.2016.4711. Epub 2016 Jun 14. Oncol Lett. 2016. PMID: 27446412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page